BlackRock Investment Management’s Apyx Medical APYX Stock Holding History

BlackRock Investment Management’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$16K	Hold	4,482	–	–	﹤0.01%	3442
2016 Q3	$23K	Sell	4,482 -319	-7%	-$1.03K	﹤0.01%	3342
2016 Q2	$8K	Hold	4,801	–	–	﹤0.01%	3704
2016 Q1	$8K	Hold	4,801	–	–	﹤0.01%	3684
2015 Q4	$10K	Hold	4,801	–	–	﹤0.01%	3673
2015 Q3	$9K	Buy	4,801 +827	+21%	+$1.9K	﹤0.01%	3719
2015 Q2	$11K	Buy	3,974 +364	+10%	+$1K	﹤0.01%	3668
2015 Q1	$9K	Buy	3,610 +708	+24%	+$2.35K	﹤0.01%	3682
2014 Q4	$11K	Hold	2,902	–	–	﹤0.01%	3632
2014 Q3	$12K	Buy	2,902 +19	+0.7%	+$77	﹤0.01%	3577
2014 Q2	$10K	Buy	+2,883	New	+$11.7K	﹤0.01%	3625

Other funds holding APYX

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

EMFAT

Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock Investment Management's APYX Position: Q4 2016 in Review

BlackRock Investment Management held its Apyx Medical (APYX) position steady in Q4 2016 at 4,482 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #3442.

BlackRock Investment Management first reported a position in APYX in Q2 2014 and has held it in 11 quarters since. The position peaked at $23K in Q3 2016. 39 funds tracked by Wall St. Rank hold APYX as of Q4 2016.

BlackRock Investment Management held 4,482 shares of Apyx Medical worth $16K as of Q4 2016.
BlackRock Investment Management left its Apyx Medical share count unchanged in Q4 2016.
Apyx Medical made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3442 holding.
BlackRock Investment Management first reported a position in Apyx Medical in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Apyx Medical position peaked at $23K in Q3 2016.
39 funds tracked by Wall St. Rank held Apyx Medical as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.